Inhibitory effect of glucocorticoid on coronary artery endothelial function

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 283, Issue 5 52-5, 2002, Pages

  Rogers, Kestrel M ^a   Bonar, Christi A ^a   Estrella, Jaymie L ^a   Yang, Shumei ^a  

^a CALIFORNIA STATE UNIVERSITY   (United States)

Author keywords

Endothelial cell; Endothelial nitric oxide synthase; Nitric oxide

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; ADENOSINE TRIPHOSPHATE; CARBENOXOLONE; CYCLOHEXIMIDE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE;

ANIMAL CELL; ARTERY CONSTRICTION; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CHEMOLUMINESCENCE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; DOWN REGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; STRESS; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

EID: 0036839107     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00364.2002     Document Type: Article

References (53)

1. Andries LJ, Brutsaert DL, and Sys SU. Nonuniformity of endothelial constitutive nitric oxide synthase distribution in cardiac endothelium. Circ Res 82: 195-203, 1998.
2. 2+ responses in rat aortic smooth muscle cells: Effect of dexamethasone. Biochem Pharmacol 58: 177-182, 1999.
3. Best R, Nelson SM, and Walker BR. Dexamethasone and 11-dehydrodexamethasone as tools to investigate the isozymes of 11β-hydroxysteroid dehydrogenase in vitro and in vivo. J Endocrinol 153: 41-48, 1997.
4. Bodin P and Burnstock G. Purinergic signalling: ATP release. Neurochem Res 26: 959-969, 2001.
5. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
6. Brem AS, Bina RB, Hill N, Alia C, and Morris DJ. Effects of licorice derivatives on vascular smooth muscle function. Life Sci 60: 207-214, 1997.
7. Brem AS, Bina RB, King TC, and Morris DJ. Localization of 2 11β-OH steroid deghydrogenase isoforms in aortic endothelial cells. Hypertension 31: 459-462, 1998.
8. Britten MB, Zeiher AM, and Schächinger V. Clinical importance of coronary endothelial vasodilator dysfunction and therapeutic options. J Intern Med 245: 315-327, 1999.
9. Browning R, Gissendanner SJ, and Wakefield T. Ergotamine alters plasma concentrations of glucagons, insulin, cortisol, and triiodothyronine in cows. JAnim Sci 78: 690-698, 2000.
10. Burnstock G and Williams M. P2 purinergic receptors: Modulation of cell function and therapeutic potential. J Pharmacol Exp Ther 295: 862-869, 2000.
11. Chen G and Suzuki H. Calcium dependency of the endothelium-dependent hyperpolarization in smooth muscle cells of the rabbit carotid artery. J Physiol 421: 521-534, 1990.
12. Diederich S, Hanke B, Burkhardt P, Müller M, Schöneshöfer M, Bähr V, and Oelkers W. Metabolism of synthetic corticosteroids by 11β-hydroxysteroid dehydrogenases in man. Steroids 63: 271-277, 1998.
13. Eyre LJ, Rabbitt EH, Hughes SV, Cooper MS, Sheppard MC, Stewart PM, and Hewison M. Expression of 11β-hydroxysteroid dehydrogenase in rat osteoblastic cells: Pre-receptor regulation of glucocorticoid responses in bone. J Cell Biochem 81: 453-462, 2001.
14. Felley-Bosco E, Bender FC, Courjault-Gautier F, Bron C, and Quest AFG. Caveolin-1 down-regulates inducible nitric oxide synthase via the proteasome pathway in human colon carcinoma cells. Proc Natl Acad Sci USA 97: 14334-14339, 2000.
15. Ferrari P, Smith RE, Funder JW, and Krozowski ZS. Substrate and inhibitor specificity of the cloned human 11β-hydroxysteroid dehydrogenase type 2 isoform. Am J Physiol Endocrinol Metab 270: E900-E904, 1996.
16. 2: A preliminary report. J Lab Clin Med 128: 115-121, 1996.
17. Fleming I and Busse R. Signal transduction of eNOS activation. Cardiovasc Res 43: 532-541, 1999.
18. 2+-independent mechanisms. In: Nitric Oxide Biology and Pathobiology (1st Ed.), edited by Ignarro LJ. New York: Academic, 2000, p. 621-632.
19. Förstermann U, Boissel JP, and Kleinert H. Expressional control of the "constitutive" isoforms of nitric oxide synthase (NOS I and NOS II). FASEB J 12: 773-790, 1998.
20. Garcia-Cardefia G, Fan R, Shah V, Sorrentino R, Cirino G, Papapetropoulos A, and Sessa WC. Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature 392: 821-824, 1998.
21. Harden KT, Nicholas RA, Schachter JB, Lazarowski ER, and Boyer JL. Pharmacological selectivities of molecularly defined subtypes of P2Y receptors. In: The P2 Nucleotide Receptors (1st Ed.), edited by Turner JT, Weisman GA, and Fedan JS. Totowa, NJ: Humana, 1998, p. 109-134.
22. 2+ induced by antigen. Biochim Biophys Acta 1051: 203-206, 1990.
23. Inoue H, Umesono K, Nishimori T, Hirata Y, and Tanabe T. Glucocorticoid-mediated suppression of the promoter activity of the cyclooxygenase-2 gene is modulated by expression of its receptor in vascular endothelial cells. Biochem Biophys Res Commun 254: 292-298, 1999.
24. Jun SS, Chen Z, Pace MC, and Shaul PW. Glucocorticoids downregulate cyclooxygenase-1 gene expression and prostacyclin synthesis in fetal pulmonary artery endothelium. Circ Res 84: 193-200, 1999.
25. Kan H, Ruan Y, and Malik KU. Signal transduction medhanism(s) involved in prostacyclin production elicited by acetylcholine in coronary endothelial cells of rabbit heart. J Pharmacol Exp Ther 282: 113-122, 1997.
26. Kone BC. Protein-protein interactions controlling nitric oxide synthases. Acta Physiol Scand 168: 27-31, 2000.
27. Kone BC. Molecular biology of natriuretic peptides and nitric oxide synthases. Cardiovasc Res 51: 429-441, 2001.
28. Kop WJ. Acute and chronic psychological risk factors for coronary syndromes: Moderating effects of coronary artery disease severity. J Psychosom Res 43: 167-181, 1997.
29. 2+ influx in vascular smooth muscle in vivo. Endocr Res 21: 203-210, 1995.
30. Krozowski Z, Li KXZ, Koyama K, Smith RE, Obeyesekere VR, Stein-Oakley A, Sasano H, Coulter C, Cole T, and Sheppard KE. The type I and type II 11β-hydroxysteroid dehydrogenase enzymes. J Steroid Biochem Mol Biol 69: 391-401, 1999.
31. Kuo L, Davis MJ, and Chilian WM. Longitudinal gradients for endothelium-dependent and -independent vascular responses in the coronary microcirculation. Circulation 92: 518-525, 1995.
32. Munck A and Náray-Fejes-Tóth A. The ups and downs of glucocorticoid physiology permissive and suppressive effects revisited. Mol Cell Endocrinol 90: C1-C4, 1992.
33. Napoli C and Ignarro LJ. Nitric oxide and atherosclerosis. Nitric Oxide 5: 88-97, 2001.
34. Page N, Warriar N, and Govindan MV. 11β-Hydroxysteroid dehydrogenase activity in human lung cells and transcription regulation by glucocorticoids, Am J Physiol Lung Cell Mol Physiol 267: L464-L474, 1994.
35. Passaquin AC, Lhote P, and Rüegg UT. Calcium influx inhibition by steroids and analogs in C2C12 skeletal muscle cells. Br J Pharmacol 124: 1751-1759, 1998.
36. Pratt WB and Toft DO. Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr Rev 18: 306-361, 1997.
37. Rosenstock M, Katz S, and Danon A. Glucocorticoids regulate both phorbol ester and calcium ionophore-induced endothelial prostacyclin synthesis. Prostaglandins Leukot Essent Fatty Acids 56: 1-8, 1997.
38. Saito T, Itoh H, Chun TH, Fukunaga Y, Yamashita J, Doi K, Tanaka T, Inoue M, Masatsugu K, Sawada N, Sakaguchi S, Arai H, Mukoyama M, Tojo K, Hosoya T, and Nakao K. Coordinate regulation of endothelin and adrenomedullin secretion by oxidative stress in endothelial cells. Am J Physiol Heart Circ Physiol 281: H1364-H1371, 2001.
39. Sapolsky RM, Romero ML, and Munck AU. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev 21: 55-89, 2000.
40. Schlegel A, Volonté D, Engelman JA, Galbiati F, Mehta P, Zhang XL, Scherer PE, and Lisanti MP. Crowded little caves: Structure and function of caveolae. Cell Signal 10: 457-463, 1998.
41. Selye H. A syndrome produced by diverse noxious agents. Nature 138: 32-36, 1936.
42. Stewart PM. Cortisol as a mineralocorticoid in human disease. J Steroid Biochem Mol Biol 69: 403-408, 1999.
43. Tabata I, Atomi Y, and Miyashita M. Blood glucose concentration dependent ACTH and cortisol responses to prolonged exercise. Clin Physiol 4: 299-307, 1984.
44. Ullian ME, Islam MM, Robinson CJ, Fitzgibbon WR, Tobin ET, and Paul RV. Resistance to mineralocorticoids in Wistar-Furth rats. Am J Physiol Heart Circ Physiol 272: H1454-H1461, 1997.
45. Veissier I, Van Reenen CG, Andanson S, and Leushuis LE. Adrenocorticotropic hormone and cortisol in calves after cotricotropin-releasing hormone. J Anim Sci 77: 2047-2053, 1999.
46. Vials AJ and Burnstock G. Differential effects of ATP- and 2-methylthio ATP-induced relaxation in guinea pig coronary vasculature. J Cardiovasc Physiol 23: 757-764, 1994.
47. Walker G, Pfeilschifter J, and Kunz D. Mechanisms of suppression of inducible nitric-oxide synthase (iNOS) expression in interferon (IFN)-γ-stimulated RAW 264.7 cells by dexamethasone. J Biol Chem 272: 16679-16687, 1997.
48. Wallerath T, Witte K, Schiifer SC, Schwarz PM, Prellwitz W, Wohlfart P, Kleinert H, Lehr HA, Lemmer B, and Förstermann U. Down-regulation of the expression of endothelial NO synthase is likely to contribute to glucocorticoid-mediated hypertension. Proc Natl Acad Sci USA 96: 13357-13362, 1999.
49. West JB (Editor). Best and Taylor's Physiological Basis of Medical Practice (12th Ed.). Baltimore, MD: Williams & Wilkins, 1991.
50. White PC, Mune T, and Agarwal AK. 11β-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess. Endocr Rev 18: 135-156, 1997.
51. x release in human coronary artery endothelium. J Cardiovasc Pharmacol 36: 242-247, 2000.
52. Yang S, Buxton ILO, Probert CB, Talbot JN, and Bradley ME. Evidence for a discrete UTP receptor in cardiac endothelial cells. Br J Pharmacol 117: 1572-1578, 1996.
53. Yang S, Cheek DJ, Westfall DP, and Buxton ILO. Purinergic axis in cardiac blood vessels agonist-mediated release of ATP from cardiac endothelial cells. Circ Res 74: 401-407, 1994.